Found: 42
Select item for more details and to access through your institution.
A Multisite, Randomized Controlled Clinical Trial of Computerized Cognitive Remediation Therapy for Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 6, p. 1387, doi. 10.1093/schbul/sbv059
- By:
- Publication type:
- Article
Vaccine Therapy in Non-Small Cell Lung Cancer.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 740, doi. 10.3390/vaccines10050740
- By:
- Publication type:
- Article
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Product Review
Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
- Published in:
- Scientific Reports, 2015, p. 17499, doi. 10.1038/srep17499
- By:
- Publication type:
- Article
Targeting PD-I/PD-LI in lung cancer: current perspectives.
- Published in:
- Lung Cancer: Targets & Therapy, 2015, v. 6, p. 55, doi. 10.2147/LCTT.S55176
- By:
- Publication type:
- Article
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung Cancer.
- Published in:
- Drugs, 2020, v. 80, n. 3, p. 241, doi. 10.1007/s40265-019-01240-8
- By:
- Publication type:
- Article
Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053645
- By:
- Publication type:
- Article
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09734-5
- By:
- Publication type:
- Article
The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2974, doi. 10.3390/cancers16172974
- By:
- Publication type:
- Article
P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular Correlation.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2719, doi. 10.3390/cancers15102719
- By:
- Publication type:
- Article
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non–Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2084, doi. 10.3390/cancers13092084
- By:
- Publication type:
- Article
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1124, doi. 10.3390/cancers12051124
- By:
- Publication type:
- Article
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 2, p. 350, doi. 10.1002/1878-0261.12861
- By:
- Publication type:
- Article
Study protocol of a randomized clinical trial evaluating the effectiveness of a primary care intervention using the Nintendo™ Wii console to improve balance and decrease falls in the elderly.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PD-L1 expression testing in non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918763493
- By:
- Publication type:
- Article
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758834017749748
- By:
- Publication type:
- Article
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 3, p. 554, doi. 10.1093/clinchem/hvaa248
- By:
- Publication type:
- Article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 3, p. 751, doi. 10.1373/clinchem.2016.265314
- By:
- Publication type:
- Article
Advances in immunotherapy for treatment of lung cancer.
- Published in:
- Cancer Biology & Medicine, 2015, v. 12, n. 3, p. 209, doi. 10.7497/j.issn.2095-3941.2015.0032
- By:
- Publication type:
- Article
Assays for predicting and monitoring responses to lung cancer immunotherapy.
- Published in:
- Cancer Biology & Medicine, 2015, v. 12, n. 2, p. 87, doi. 10.7497/j.issn.2095-3941.2015.0019
- By:
- Publication type:
- Article
Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints.
- Published in:
- Cancer Biology & Medicine, 2015, v. 12, n. 2, p. 79, doi. 10.7497/j.issn.2095-3941.2015.0029
- By:
- Publication type:
- Article
Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
- Published in:
- Histopathology, 2024, v. 84, n. 7, p. 1154, doi. 10.1111/his.15160
- By:
- Publication type:
- Article
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, PD‐L1 copy number alterations, and outcome
- Published in:
- Histopathology, 2019, v. 75, n. 6, p. 799, doi. 10.1111/his.13857
- By:
- Publication type:
- Article
RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 4, p. 470, doi. 10.1093/carcin/bgr003
- By:
- Publication type:
- Article
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 9, p. 1420, doi. 10.1038/s41416-024-02607-9
- By:
- Publication type:
- Article
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 434, doi. 10.1038/s41416-023-02513-6
- By:
- Publication type:
- Article
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 778, doi. 10.1007/s10120-015-0545-5
- By:
- Publication type:
- Article
PD-L1 Expression in Non-Small Cell Lung Cancer: Data from a Referral Center in Spain.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1452, doi. 10.3390/diagnostics11081452
- By:
- Publication type:
- Article
The Importance of STK11 / LKB1 Assessment in Non-Small Cell Lung Carcinomas.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 2, p. 196, doi. 10.3390/diagnostics11020196
- By:
- Publication type:
- Article
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 11, p. 902, doi. 10.3390/diagnostics10110902
- By:
- Publication type:
- Article
Molecular Markers and Targets in Melanoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2320, doi. 10.3390/cells10092320
- By:
- Publication type:
- Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
- By:
- Publication type:
- Article
Prevalence of injuries in the field of primary care in view of the record-keeping variations.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 1117, doi. 10.2147/OTT.S148363
- By:
- Publication type:
- Article
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 3, p. 318, doi. 10.5858/arpa.2022-0443-OA
- By:
- Publication type:
- Article
RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 4, p. 474, doi. 10.5858/arpa.2017-0134-RA
- By:
- Publication type:
- Article
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9506, doi. 10.3390/ijms25179506
- By:
- Publication type:
- Article
Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
- Published in:
- Cancer Science, 2024, v. 115, n. 5, p. 1505, doi. 10.1111/cas.16141
- By:
- Publication type:
- Article
TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/393064
- By:
- Publication type:
- Article
Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 4, p. 356, doi. 10.1093/ced/llad405
- By:
- Publication type:
- Article